Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Patients with atrial fibrillation and stable coronary artery disease were assigned to receive either rivaroxaban monotherapy or combination therapy with rivaroxaban plus a single antiplatelet agent. At 2 years, monotherapy was noninferior to combination therapy with respect to ischemic events and superior with respect to major bleeding.
Alternative Titles
Full title
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2293073316
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2293073316
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1904143
